Jackson Grant Investment Advisers’s L3Harris LHX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24.1K Hold
83
0.01% 252
2026
Q1
$28.6K Hold
83
0.01% 237
2025
Q4
$24.4K Hold
83
0.01% 246
2025
Q3
$25.3K Hold
83
0.01% 239
2025
Q2
$20.8K Hold
83
0.01% 228
2025
Q1
$17.4K Hold
83
0.01% 233
2024
Q4
$17.5K Hold
83
0.01% 236
2024
Q3
$19.7K Hold
83
0.01% 233
2024
Q2
$18.6K Hold
83
0.01% 237
2024
Q1
$17.7K Hold
83
0.01% 231
2023
Q4
$17.5K Hold
83
0.01% 228
2023
Q3
$14.5K Hold
83
0.01% 236
2023
Q2
$16.2K Hold
83
0.01% 235
2023
Q1
$16.3K Buy
83
+18
+28% +$3.68K 0.01% 270
2022
Q4
$13.5K Hold
65
0.01% 280
2022
Q3
$14K Hold
65
0.01% 286
2022
Q2
$16K Hold
65
0.01% 287
2022
Q1
$16K Hold
65
0.01% 304
2021
Q4
$14K Hold
65
0.01% 253
2021
Q3
$14K Hold
65
0.01% 312
2021
Q2
$14K Buy
65
+12
+23% +$2.58K 0.01% 328
2021
Q1
$11K Buy
+53
New +$9.94K 0.01% 334

Other funds holding LHX

Jackson Grant Investment Advisers's LHX Position: Q2 2026 in Review

Jackson Grant Investment Advisers held its L3Harris (LHX) position steady in Q2 2026 at 83 shares worth $24.1K. The position accounts for 0.01% of the portfolio, ranked #252.

Jackson Grant Investment Advisers first reported a position in LHX in Q1 2021 and has held it in 22 quarters since. The position peaked at $28.6K in Q1 2026. 746 funds tracked by Wall St. Rank hold LHX as of Q2 2026.

  • Jackson Grant Investment Advisers held 83 shares of L3Harris worth $24.1K as of Q2 2026.
  • Jackson Grant Investment Advisers left its L3Harris share count unchanged in Q2 2026.
  • L3Harris made up 0.01% of Jackson Grant Investment Advisers's portfolio in Q2 2026, its #252 holding.
  • Jackson Grant Investment Advisers first reported a position in L3Harris in Q1 2021 and has held it in 22 quarters since.
  • Jackson Grant Investment Advisers's L3Harris position peaked at $28.6K in Q1 2026.
  • 746 funds tracked by Wall St. Rank held L3Harris as of Q2 2026.

Based on Jackson Grant Investment Advisers's 13F filing for Q2 2026, filed 31 Jul 2026.